# OnCo record abexinostat (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/abexinostat/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "abexinostat" ;
  schema:name "Abexinostat"@en ;
  schema:description "Abexinostat is an experimental small-molecule drug from Xynomic Pharmaceuticals in phase 3 trials for renal cell carcinoma, diffuse large B-cell lymphoma and follicular lymphoma, with its target not yet stated publicly."@en ;
  schema:url <https://onco.cc/drugs/abexinostat/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=PCI-24781> ;
  onco:status "phase-3" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "small molecule" ;
  onco:cancers <https://onco.cc/cancers/rcc/>, <https://onco.cc/cancers/dlbcl/>, <https://onco.cc/cancers/follicular-lymphoma/>, <https://onco.cc/cancers/hodgkin-lymphoma/> ;
  onco:companies <https://onco.cc/companies/xynomic-pharmaceuticals/> ;
  onco:trials <https://onco.cc/trials/renaviv/>, <https://onco.cc/trials/nct03600441/>, <https://onco.cc/trials/nct03936153/>, <https://onco.cc/trials/nct04024696/>, <https://onco.cc/trials/nct03934567/> .